Back to results
US 10,293,019 B2Granted
Pharmaceutical composition for treatment of or remission in elderly or terminal cancer patient
AssigneeDelta-Fly Pharma, Inc.
InventorHiromi Wada
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a novel treatment method with fewer side effects for elderly cancer patients and terminal cancer patients. A pharmaceutical composition for treating or putting an elderly or a terminal cancer patient into remission, comprising, as an active ingredient, (2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoylamino]-4-methylpentanoic acid or a pharmacologically acceptable salt thereof.
Claims2
A method for treating or putting into remission a patient in need thereof, said method comprising:
- selecting a solid cancer patient aged 70 or more or a terminal solid cancer patient, the patient's neutrophil count to lymphocyte count ratio in peripheral blood being 4 or more or the patient's platelet count to lymphocyte count ratio being 1.5 or more, wherein the peripheral blood of said cancer patient has a normal range of platelet counts or a normal range of neutrophil counts;
- and
- administering to said patient a composition comprising, as an active ingredient, sufficient (2S)-2- [(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoylamino]-4-methylpentanoic acid or a pharmacologically acceptable salt thereof to provide said patient with a dosage 10 mg/body/day.
Dependencies are inferred from the claim text.